ALT elevations can reflect metabolic dysfunction–associated steatotic liver disease (MASLD/NAFLD) [41], which is linked to heightened atherosclerotic cardiovascular risk [42,43]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.